Catheter Precision, Inc. — Director's Dealing 2023

Jan 11, 2023

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Ra Medical Systems, Inc. (RMED)
CIK: 0001716621
Period of Report: 2023-01-09

Reporting Person: JENKINS DAVID A (Director, Executive Chairman of Board)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2023-01-09	Series X Convertible Preferred Stock	$	A	2569.936	Acquired		Common Stock (2569936)	Direct
2023-01-09	Series X Convertible Preferred Stock	$	A	20.955	Acquired		Common Stock (20955)	Indirect
2023-01-09	Series X Convertible Preferred Stock	$	A	6570.243	Acquired		Common Stock (6570243)	Indirect

Footnotes

F1: Following stockholder approval of the conversion of Series X Convertible Preferred Stock into shares of Common Stock, each share of Series X Convertible Preferred Stock automatically converts into 1,000 shares of Common Stock, subject to certain limitations.

F2: On January 9, 2023, the Issuer, completed its acquisition of Catheter Precision, Inc., a privately-held Delaware corporation ("Catheter"), pursuant to an Amended and Restated Agreement and Plan of Merger (the "Merger"). In connection with the Merger, each share of Catheter common stock previously outstanding held by the reporting person now represents a number of shares of Series X Convertible Preferred Stock equal to approximately 0.6697, divided by one thousand (1,000).

F3: Series X Convertible Preferred Stock has no expiration date

F4: Shares held by charitable remainder unitrust of which the reporting person's spouse is the trustee.

F5: Shares held by a partnership of which the reporting person is the managing member of the managing partner.